Zebrafish embryonically exposed to valproic acid present impaired retinal development and sleep behavior

Area of Science:

• Neuroscience
• Developmental Biology
• Pharmacology

Background:

• Valproic acid (VPA) is a known risk factor for autism spectrum disorder (ASD).
• Visual processing is crucial for social behaviors relevant to ASD.
• Zebrafish serve as a model to study ASD-like phenotypes.

Purpose of the Study:

• To investigate the impact of embryonic valproic acid (VPA) exposure on the visual system and sleep regulation in zebrafish.
• To explore potential links between VPA-induced developmental changes and ASD-related behavioral deficits.

Main Methods:

• Histological analysis of retinal and optic nerve development.
• Behavioral assays to assess sleep-like patterns.
• Gene expression analysis of neurotransmitter systems (serotonin, hypocretin/orexin).

Main Results:

• VPA exposure caused transient delays in zebrafish retina and optic nerve development.
• Larval zebrafish exposed to VPA exhibited sleep disturbances.
• Reduced serotonin-producing cells in the pineal gland and hypocretin/orexin neurons in the hypothalamus were observed.

Conclusions:

• Embryonic VPA exposure in zebrafish does not permanently impair larval visual function despite initial developmental delays.
• VPA significantly alters cellular mechanisms regulating sleep, providing a potential model for understanding sleep disturbances in ASD.